{ Economic Modeling }
Our Health Economics team has long provided key strategic economic support, from both health economics and outcomes research at Fortune 100 companies and from serving as consultants to major pharmaceutical, biotech, and medical device customers. Our models have been used with providers, administrators, payers, government agencies, and state and national legislators. From establishing burden of illness and new product landscape to modeling the cost per Quality Adjusted Life Years for NICE to modeling the 18-month budget impact and value proposition for US commercial payers, our team creates models that your field force will be comfortable delivering and which your customers will find accessible and meaningful. Our services include:
- Burden of illness studies
- Incidence, prevalence, and natural history of disease
- Practice patterns, healthcare resource use, and comparator costs
- Budget impact modeling: budget minimization, cost-offset, etc.
- Cost-effectiveness modeling: life years gained, quality adjusted life years
- Customer acceptability testing for economic models and tools
- Support for economic endpoints in Phase II–IV trials
